Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
Completed
- Conditions
- Thyroid Nodule
- Registration Number
- NCT00571090
- Lead Sponsor
- Istanbul Science University
- Brief Summary
The aim of this study is to identify which ultrasonographic feature or a combination of features is the best predictor of thyroid cancer in thyroid nodules.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 735
Inclusion Criteria
- Subjects with thyroid nodules over 10 mm in the longest diameter
- Euthyroid or hypothyroid subjects with a solitary thyroid nodule or multinodular goiter
- Subjects with a hypoactive nodule in the thyroid scan and a low TSH
Exclusion Criteria
- Subjects with four or more thyroid nodules that are over 10 mm
- Subjects with low TSH and hyperactive nodule on thyroid scan
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid cancer one year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What ultrasonographic features correlate with BRAF mutation status in thyroid nodules?
How does thyroid ultrasonography compare to molecular testing for cancer prediction in Nodular Goiter patients?
Which biomarkers improve cancer detection rates when combined with ultrasound in thyroid nodules?
What are the adverse events associated with thyroid fine needle aspiration biopsy in NCT00571090?
How do ultrasonographic characteristics predict cancer risk in benign vs. malignant thyroid nodule subtypes?
Trial Locations
- Locations (1)
Group Florence Nightingale
🇹🇷Istanbul, Turkey
Group Florence Nightingale🇹🇷Istanbul, Turkey